US05463X1063
US05463X1063
AxoGen, Inc.
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 2.12B EUR | 2.46B EUR | 1.76B EUR | 1.54B EUR |
Enterprise Value | 1.85B EUR | 2.38B EUR | 1.7B EUR | 1.58B EUR |
Valuation Multiples | ||||
Trailing P/E | -- | -- | -- | -- |
Forward P/E | 52.51x | -- | -- | -- |
Price to Sales | 8.44x | 9.78x | 7.4x | 8.75x |
Price to Book | 7.56x | 9.59x | 7.19x | 11.99x |
EV/Revenue | 7.38x | 9.48x | 7.14x | 8.93x |
EV/EBITDA | -310.61x | -- | -- | 2,456.28x |
Price to FCF (P/FCF) | 116.26x | 377.31x | 229.92x | 170.55x |
EV/FCF | 101.67x | 365.86x | 221.83x | 174.09x |
FCF Yield | 0.86% | 0.27% | 0.43% | 0.59% |